This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Yeda Research and Develpment & Co. Ltd. Active years: 2024.
Company Filing History:
1 out of 60 
1 out of 1,168 Years Active: 2024
Title: Shimrit Lieber: Innovator in T Cell Culturing Methods
Introduction
Shimrit Lieber is a notable inventor based in Rehovot, Israel. She has made significant contributions to the field of immunology, particularly in the culturing of T cells. Her innovative methods have the potential to advance therapeutic applications in various medical fields.
Latest Patents
Shimrit Lieber holds a patent for "Methods of culturing T cells and uses of same." This patent describes a method of culturing T cells that involves the presence of a T cell stimulator, exogenous CCL21, and exogenous ICAM1. The method allows for the effective culturing of T cells, leading to the development of cell cultures and isolated T cells with various applications.
Career Highlights
Throughout her career, Shimrit has worked with esteemed organizations such as the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yeda Research and Development & Co. Ltd. Her work has been instrumental in advancing research in T cell biology and its applications in medicine.
Collaborations
Shimrit has collaborated with notable colleagues, including Anat Globerson Levin and Benjamin Geiger. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Shimrit Lieber's contributions to T cell culturing methods exemplify her dedication to advancing medical research. Her innovative approaches and collaborations continue to influence the field of immunology.